Category: Parkinson’s News

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

Northwestern University’s Daniel Corcos is testing whether high-intensity aerobic exercise can slow Parkinson’s progression.

Even though aging is the largest risk factor for Parkinson’s disease, the majority of research aimed at taming the able neurodegenerativeincur motor disease has largely left aging out of the mix.

Wrexham owners Ryan Reynolds and Rob Mac tell manager Phil Parkinson he has a “job for life” after describing him as “integral” to the club’s rise.

ParKLIMson founder Ton van den Berg: “My ambition is to set up a Parkinson’s group in every climbing gym in the Netherlands”

An “extraordinary” brain network discovery shows that Parkinson’s disease may not be a movement disorder after all

A newly identified brain network may be the real driver of Parkinson’s—and precisely targeting it just delivered a major boost in symptom relief.

A study shows how the Parkinson’s protein alpha-synuclein harms brain cells by disrupting mitochondria.

Brain tissue analysis shows reactive microglia in Parkinson’s disease overexpress Fc gamma receptors, which may lead to inappropriate elimination of functional dopaminergic neurons. These findings suggest a treatment target for Parkinson’s disease.